Development of a Scalable Synthesis of Gastrazole (JB95008): A Potent CCK2 Receptor Antagonist
- 24 June 2005
- journal article
- review article
- Published by American Chemical Society (ACS) in Organic Process Research & Development
- Vol. 9 (4), 499-507
- https://doi.org/10.1021/op0500638
Abstract
No abstract availableKeywords
This publication has 9 references indexed in Scilit:
- Use of a novel CCKB/gastrin receptor antagonist, gastrazole (JB5008) in patients with advanced pancreatic adenocarcinoma. Results of an open labeled pilot trialGastroenterology, 2001
- Protective Groups in Organic SynthesisPublished by Wiley ,1999
- The reaction of phthalidylidene dichloride with primary amines. Synthesis and X-ray molecular structure of N-substituted phthalisoimidesTetrahedron, 1997
- Non-Peptide Cholecystokinin-B/Gastrin Receptor Antagonists Based on Bicyclic, Heteroaromatic SkeletonsJournal of Medicinal Chemistry, 1996
- Improving the Affinity and Selectivity of a Nonpeptide Series of Cholecystokinin-B/Gastrin Receptor Antagonists Based on the Dibenzobicyclo[2.2.2]octane SkeletonJournal of Medicinal Chemistry, 1995
- A new method for the synthesis of n-arylphthalisoimidesTetrahedron Letters, 1991
- New convenient reagent for peptide synthesesJournal of the American Chemical Society, 1968
- Syntheses of Unsymmetric o-Phthalic Acid DiamidesJournal of Medicinal Chemistry, 1967
- Action of Trifluoroacetic Anhydride on N-Substituted Amic Acids1,2The Journal of Organic Chemistry, 1963